Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
about
Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New ZealandObesity and the extent of liver damage among adult New Zealanders: findings from a national survey.Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse ReactionCost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.A liver health hui: hepatitis C knowledge and associated risk factors in New Zealand gang members and their families
P2860
Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
@en
type
label
Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
@en
prefLabel
Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
@en
P2093
P1476
Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand
@en
P2093
Catherine Stedman
Charles Henderson
Cheryl Brunton
Edward Gane
Homie Razavi
Sarah Radke
P407
P50
P577
2014-12-19T00:00:00Z